Allen Yang
Nessuna posizione attualmente
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Allen Yang worked as a Medical Director at Amgen, Inc. and as a Vice President of Clinical Research at Spectrum Pharmaceuticals, Inc. He then became the Chief Medical Officer and Senior Vice President at Xencor, Inc. from 2019 to 2023.
He also worked as the VP and Therapeutic Area Head of Hematology/Oncology at Jazz Pharmaceuticals Plc.
Dr. Yang holds a doctorate from the University of Southern California and an undergraduate degree from the University of California, Berkeley.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
XENCOR, INC.
0.12% | 09/03/2023 | 73 364 ( 0.12% ) | 2 M $ | 31/03/2024 |
Precedenti posizioni note di Allen Yang
Società | Posizione | Fine |
---|---|---|
XENCOR, INC. | Chief Tech/Sci/R&D Officer | 01/05/2023 |
AMGEN INC. | Corporate Officer/Principal | - |
SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/01/2019 |
Formazione di Allen Yang
University of Southern California | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AMGEN INC. | Health Technology |
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
XENCOR, INC. | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
- Borsa valori
- Insiders
- Allen Yang